Phaxiam Therapeutics Revenue Growth & History (PHXM)

Phaxiam Therapeutics reported €1.3M in revenue for fiscal 2023, a decrease of 95.72% from the previous fiscal year.

View full Phaxiam Therapeutics company overview

Phaxiam Therapeutics annual revenue and growth

Phaxiam Therapeutics annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20232023-12-31€1.3M−€29.7M−95.72%
20222022-12-31€31.0M€26.8M+641.58%
20212021-12-31€4.2M

Phaxiam Therapeutics revenue growth trends

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review Phaxiam Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about PHXM yet. Start the conversation.

Write the first post